Advanced Brain Tumor Care, Close to Home - Report - MDSpire

Advanced Brain Tumor Care, Close to Home

  • By

  • May 28, 2026

  • 2 min

Share

Clinical Report: Advanced Brain Tumor Care, Close to Home

Overview

The Marcus Neuroscience Institute offers a multidisciplinary approach to brain tumor care, integrating advanced technologies and specialized teams.

Background

Brain tumors present significant challenges in diagnosis and treatment, often requiring a coordinated approach to care.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • The Marcus Neuroscience Institute provides a multidisciplinary team approach for brain tumor patients.
  • Advanced technologies such as minimally invasive surgery and intraoperative MRI are utilized.
  • Patients can often be seen within 24 hours for urgent brain tumor concerns.
  • Proton therapy is available.
  • Comprehensive care includes access to clinical trials and supportive therapies.

Clinical Implications

The multidisciplinary model at Marcus Neuroscience Institute highlights the importance of coordinated care in managing brain tumors. Timely access to specialized services can significantly impact patient experiences and outcomes.

Conclusion

The integration of advanced treatment options and a collaborative care team at Marcus Neuroscience Institute represents a significant advancement in brain tumor management, providing patients with comprehensive support close to home.

Related Resources & Content

  1. The ASCO Post, 2013 -- Improving Treatment and Care for Patients with Primary Brain Cancers
  2. Journal of Neuro-Oncology, 2017 -- Neuro-oncology family caregivers’ view on keeping track of care issues using eHealth systems: it’s a question of time
  3. The ASCO Post, 2013 -- Association of Community Cancer Centers' 2013 Innovator Award Recipients Announced
  4. Journal of Clinical Oncology, 2025 -- Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update
  5. ASTRO, 2025 -- ASTRO updates guideline on radiation therapy for high-grade diffuse glioma
  6. atlantic health system — Advanced Breast Imaging Backed by Specialized Clinical Care
  7. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update | Journal of Clinical Oncology
  8. ASTRO updates guideline on radiation therapy for high-grade diffuse glioma - American Society for Radiation Oncology (ASTRO)
  9. Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update - PubMed

Original Source(s)

Advanced Brain Tumor Care, Close to Home

  • by

  • May 28, 2026

Related Content

TAILORx and RxPONDER Trials Shift to a Discovery Platform

The ECOG-ACRIN Cancer Research Group, in collaboration with the SWOG Cancer Research Network, has launched a new initiative to analyze paired original and recurrent tumor specimens from two practice-c...

Roving Reporter Asks: Where Is Real Progress Being Made in Manufacturing and Supply Chain?

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how automation, AI, closed systems, and smarter supply chain models are helping advanced therapies move toward scalable delivery

  • May 28, 2026

  • 1 min
BPDCN: FDA Approves Pivekimab Sunirine-pvzy

Today, the FDA approved pivekimab sunirine-pvzy (Decnupaz), a CD123-directed antibody and alkylating agent conjugate, for adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN).